Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: A preliminary case-control study

European Radiology

Volumn 23, Issue 1, 2013, Pages 156-162

  Motosugi, Utaroh ^a   Ichikawa, Tomoaki ^a   Koshiishi, Tsuyota ^a   Sano, Katsuhiro ^a   Morisaka, Hiroyuki ^a   Ichikawa, Shintaro ^a   Enomoto, Nobuyuki ^a   Matsuda, Masanori ^a   Fujii, Hideki ^a   Araki, Tsutomu ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Chronic liver disease; Elastography; Hepatocellular carcinoma; Magnetic resonance imaging; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; GADOXETIC ACID;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; ELASTOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER STIFFNESS; MAGNETIC RESONANCE ELASTOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CONTRAST MEDIA; ELASTICITY IMAGING TECHNIQUES; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84871292424     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2571-6     Document Type: Article

References (34)

1. Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172-178
2. Yoshida H, Shiratori Y, Moriyama M et al (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 131:174-181 (Pubitemid 29364999)
3. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 54:650-659
4. Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:e1202 (Pubitemid 47488968)
5. Rouviere O, Yin M, Dresner MA et al (2006) MR elastography of the liver: preliminary results. Radiology 240:440-448 (Pubitemid 44098640)
6. Motosugi U, Ichikawa T, Sou H et al (2010) Magnetic resonance elastography of the liver: preliminary results and estimation of interrater reliability. Jpn J Radiol 28:623-627
7. Asbach P, Klatt D, Schlosser B et al (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 257:80-86
8. Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458-466 (Pubitemid 47612527)
9. Klatt D, Asbach P, Rump J et al (2006) In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography. Invest Radiol 41:841-848 (Pubitemid 44747111)
10. Masuzaki R, Tateishi R, Yoshida H et al (2009) Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 49:1954-1961
11. Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L (2009) Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 19:S975-S989
12. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
13. Addley HC, Griffin N, Shaw AS et al (2011) Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol 66:349-356
14. Ichikawa T, Erturk SM, Araki T (2006) Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. Eur J Radiol 58:165-176
15. Mannelli L, Godfrey E, Joubert I et al (2010) MR elastography: spleen stiffness measurements in healthy volunteers-preliminary experience. AJR Am J Roentgenol 195:387-392
16. Manduca A, Oliphant TE, Dresner MA et al (2001) Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 5:237-254 (Pubitemid 35282809)
17. Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32-40 (Pubitemid 351899024)
18. Hines CD, Bley TA, Lindstrom MJ, Reeder SB (2010) Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging 31:725-731
19. Hines CD, Lindstrom MJ, Varma AK, Reeder SB (2011) Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging 33:239-244
20. Shire NJ, Yin M, Chen J et al (2011) Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 34:947-955
21. Inoue A, Tsukuma H, Oshima A et al (2000) Effectiveness of interferon therapy for reducing the incidence of hepatocellular carcinoma among patients with type C chronic hepatitis. J Epidemiol 10:234-240
22. Ikeda K, Saitoh S, Koida I et al (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47-53 (Pubitemid 23193616)
23. Ikeda K, Saitoh S, Suzuki Y et al (1998) Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28:930-938 (Pubitemid 28275969)
24. Ohki T, Tateishi R, Sato T et al (2008) Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 6:459-464 (Pubitemid 351443115)
25. Kiyosawa K, Umemura T, Ichijo T et al (2004) Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127:S17-S26 (Pubitemid 39423366)
26. El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127:S27-S34 (Pubitemid 39423367)
27. Masuzaki R, Tateishi R, Yoshida H et al (2008) Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography. J Clin Gastroenterol 42:839-843
28. Anaparthy R, Talwalkar JA, Yin M, Roberts LR, Fidler JL, Ehman RL (2011) Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. Aliment Pharmacol Ther 34:83-91
29. The Liver Cancer Study Group of Japan (2009) Clinical guideline of liver cancer. Kanehara, Tokyo
30. Kogita S, Imai Y, Okada M et al (2010) Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 20:2405-2413
31. Sano K, Ichikawa T, Motosugi U et al (2011) Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced magnetic resonance imaging. Radiology 261:834-844
32. Rhee H, Kim MJ, Park YN, Choi JS, Kim KS (2012) Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria. J Magn Reson Imaging 35:393-398
33. Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (≤2cm) HCC in cirrhosis. Eur Radiol 21:1233-1242
34. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749-756